|
2021 Conference Publication 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in patients with somatostatin-expressing neuroendocrine tumors: a real-world retrospective review of efficacy and safety from an Australian tertiary cancer CenterNalder, Mark, Ladwa, Rahul, Raina, Anant, Burge, Matthew E., Love, Amanda, Pattison, David A., Ramsay, Stuart and Wyld, David (2021). 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in patients with somatostatin-expressing neuroendocrine tumors: a real-world retrospective review of efficacy and safety from an Australian tertiary cancer Center. 2021 ASCO Annual Meeting I, Virtual, 4-8 June 2021. Alexandria, VA USA: American Society of Clinical Oncology. doi: 10.1200/jco.2021.39.15_suppl.e16198 |
|
2021 Journal Article Psychosocial impacts of COVID-19 upon a diverse Australian oncology workforce: From doctors to ancillary staff.Ahern, Elizabeth Stephanie, Roberts, Natasha Anne, Chan, Bryan Anthony, Gasper, Harry Michael, Pelecanos, Anita, Kennedy, Glen, Wyld, David and Lwin, Zarnie (2021). Psychosocial impacts of COVID-19 upon a diverse Australian oncology workforce: From doctors to ancillary staff.. Journal of Clinical Oncology, 39 (15_suppl), 15. doi: 10.1200/jco.2021.39.15_suppl.e23016 |
|
2021 Journal Article Semiqualitative research protocol to explore cancer care workforce perceptions of the health system response to COVID-19 preparations in Southeast Queensland, AustraliaGasper, Harry, Ahern, Elizabeth, Roberts, Natasha, Chan, Bryan, Hughes, Brett, Kennedy, Glen, Wyld, David, Eastgate, Melissa and Lwin, Zarnie (2021). Semiqualitative research protocol to explore cancer care workforce perceptions of the health system response to COVID-19 preparations in Southeast Queensland, Australia. BMJ Open, 11 (5) e044655, e044655. doi: 10.1136/bmjopen-2020-044655 |
|
2021 Journal Article Resilience and ongoing quality care for cancer clinical trials during COVID-19: experience from a tertiary hospital in AustraliaIves, Amy, Pusztai, Tricia, Keller, Jacqui, Ahern, Elizabeth, Chan, Bryan, Gasper, Harry, Wyld, David, Kennedy, Glen, Dickie, Graeme, Lwin, Zarnie and Roberts, Natasha A. (2021). Resilience and ongoing quality care for cancer clinical trials during COVID-19: experience from a tertiary hospital in Australia. Asia-Pacific Journal of Clinical Oncology, 18 (2), e141-e147. doi: 10.1111/ajco.13570 |
|
2021 Journal Article Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): the NETPET score as a prognostic biomarkerChan, David L., Ulaner, Gary A., Pattison, David A., Wyld, David, Ladwa, Rahul, Kirchner, Julian, Li, Bob T, Lai, W Victoria, Pavlakis, Nick, Roach, Paul J and Bailey, Dale L (2021). Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): the NETPET score as a prognostic biomarker. Journal of Nuclear Medicine, 62 (9), 1278-1284. doi: 10.2967/jnumed.120.257659 |
|
2021 Journal Article Hemoglobin, body mass index, and age as risk factors for Paclitaxel- and Oxaliplatin-induced peripheral neuropathyMizrahi, David, Park, Susanna B., Li, Tiffany, Timmins, Hannah C., Trinh, Terry, Au, Kimberley, Battaglini, Eva, Wyld, David, Henderson, Robert D., Grimison, Peter, Ke, Helen, Geelan-Small, Peter, Marker, Julie, Wall, Brian and Goldstein, David (2021). Hemoglobin, body mass index, and age as risk factors for Paclitaxel- and Oxaliplatin-induced peripheral neuropathy. JAMA Network Open, 4 (2) e2036695, 1-14. doi: 10.1001/jamanetworkopen.2020.36695 |
|
2021 Journal Article Incidence, survival and stage at diagnosis of small intestinal neuroendocrine tumours in Queensland, Australia, 2001-2015Wyld, David, Moore, Julie, Tran, Nancy and Youl, Philippa (2021). Incidence, survival and stage at diagnosis of small intestinal neuroendocrine tumours in Queensland, Australia, 2001-2015. Asia-Pacific Journal of Clinical Oncology, 17 (4), 350-358. doi: 10.1111/ajco.13503 |
|
2021 Journal Article Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analysesKang, Eun Young, Cheasley, Dane, LePage, Cecile, Wakefield, Matthew J., da Cunha Torres, Michelle, Rowley, Simone, Salazar, Carolina, Xing, Zhongyue, Allan, Prue, Bowtell, David D. L., Mes-Masson, Anne-Marie, Provencher, Diane M., Rahimi, Kurosh, Kelemen, Linda E., Fasching, Peter A., Doherty, Jennifer A., Goodman, Marc T., Goode, Ellen L., Deen, Suha, Pharoah, Paul D. P., Brenton, James D., Sieh, Weiva, Mateoiu, Constantina, Sundfeldt, Karin, Cook, Linda S., Le, Nhu D., Anglesio, Michael S., Gilks, C. Blake, Huntsman, David G. ... Campbell, Ian G. (2021). Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses. Modern Pathology, 34 (1), 194-206. doi: 10.1038/s41379-020-0618-9 |
|
2020 Journal Article PET imaging quantifying Ga-PSMA-11 uptake in metastatic colorectal cancerCuda, Tahleesa J., Riddell, Andrew D., Liu, Cheng, Whitehall, Vicki L., Borowsky, Jennifer, Wyld, David K., Burge, Matthew E., Ahern, Elizabeth, Griffin, Alison, Lyons, Nicholas J. R., Rose, Stephen E., Clark, David A., Stevenson, Andrew R. L., Hooper, John D., Puttick, Simon and Thomas, Paul A. (2020). PET imaging quantifying Ga-PSMA-11 uptake in metastatic colorectal cancer. The Journal of Nuclear Medicine, 61 (11), 1576-1579. doi: 10.2967/jnumed.119.233312 |
|
2020 Journal Article Statistical Process Control assessed implementation fidelity of Patient Reported Outcome Measures (PROMs) in routine careRoberts, Natasha A., Alexander, Kimberly, Wyld, David and Janda, Monika (2020). Statistical Process Control assessed implementation fidelity of Patient Reported Outcome Measures (PROMs) in routine care. Journal of Clinical Epidemiology, 127, 76-86. doi: 10.1016/j.jclinepi.2020.06.022 |
|
2020 Journal Article The utility of the implementation science framework “Integrated Promoting Action on Research Implementation in Health Services” (i-PARIHS) and the facilitator role for introducing patient-reported outcome measures (PROMs) in a medical oncology outpatient departmentRoberts, Natasha A., Janda, Monika, Stover, Angela M., Alexander, Kimberly E., Wyld, David and Mudge, Alison (2020). The utility of the implementation science framework “Integrated Promoting Action on Research Implementation in Health Services” (i-PARIHS) and the facilitator role for introducing patient-reported outcome measures (PROMs) in a medical oncology outpatient department. Quality of Life Research, 30 (11), 3063-3071. doi: 10.1007/s11136-020-02669-1 |
|
2020 Journal Article Determining the CA19-9 concentration that best predicts the presence of CT-occult unresectable features in patients with pancreatic cancer: a population-based analysisMcGahan, William, Waterhouse, Mary A., O'Connell, Dianne L., Merrett, Neil D., Goldstein, David, Wyld, David, Burmeister, Elizabeth A., Jordan, Susan J. and Neale, Rachel E. (2020). Determining the CA19-9 concentration that best predicts the presence of CT-occult unresectable features in patients with pancreatic cancer: a population-based analysis. Pancreatology, 20 (7), 1458-1464. doi: 10.1016/j.pan.2020.07.405 |
|
2020 Journal Article Trends in epidemiology, treatment and molecular testing of metastatic colorectal cancer in a real‐world multi‐institution cohort studyKuchel, Anna, Ahern, Elizabeth, Collins, Stephanie, Whitehall, Vicki, Okano, Satomi, Pelecanos, Anita, Wyld, David, Eastgate, Melissa and Burge, Matthew (2020). Trends in epidemiology, treatment and molecular testing of metastatic colorectal cancer in a real‐world multi‐institution cohort study. Asia-Pacific Journal of Clinical Oncology, 17 (1) ajco.13420, 84-93. doi: 10.1111/ajco.13420 |
|
2020 Journal Article Prognostic gene expression signature for high-grade serous ovarian cancerMillstein, J., Budden, T., Goode, E.L., Anglesio, M.S., Talhouk, A., Intermaggio, M.P., Leong, H.S., Chen, S., Elatre, W., Gilks, B., Nazeran, T., Volchek, M., Bentley, R.C., Wang, C., Chiu, D.S., Kommoss, S., Leung, S.C.Y., Senz, J., Lum, A., Chow, V., Sudderuddin, H., Mackenzie, R., George, J., Fereday, S., Hendley, J., Traficante, N., Steed, H., Koziak, J.M., Köbel, M. ... AOCS Group (2020). Prognostic gene expression signature for high-grade serous ovarian cancer. Annals of Oncology, 31 (9), 1240-1250. doi: 10.1016/j.annonc.2020.05.019 |
|
2020 Journal Article Australian experience of peptide receptor radionuclide therapy in lung neuroendocrine tumoursLim, Lisi Elizabeth, Chan, David L., Thomas, David, Du, Yang, Tincknell, Gary, Kuchel, Anna, Davis, Alexander, Bailey, Dale L., Pavlakis, Nick, Cehic, Gabrielle, Macdonald, William, Wyld, David and Segelov, Eva (2020). Australian experience of peptide receptor radionuclide therapy in lung neuroendocrine tumours. OncoTarget, 11 (27), 2636-2646. doi: 10.18632/oncotarget.27659 |
|
2020 Journal Article The (co)production of difference in the care of patients with cancer from migrant backgroundsBroom, Alex, Parker, Rhiannon, Raymond, Stephanie, Kirby, Emma, Lewis, Sophie, Kokanović, Renata, Adams, Jonathan, de Souza, Paul, Woodland, Lisa, Wyld, David, Lwin, Zarnie and Koh, Eng-Siew (2020). The (co)production of difference in the care of patients with cancer from migrant backgrounds. Qualitative Health Research, 30 (11), 1049732320930699-1631. doi: 10.1177/1049732320930699 |
|
2020 Journal Article Supporting patients and carers affected by pancreatic cancer: a feasibility study of a counselling interventionBeesley, Vanessa L., Turner, Jane M., Chan, Raymond J., Yates, Patsy, Gordon, Louisa G., Burge, Matthew, Eastgate, Melissa A., Staneva, Aleksandra A., Northfield, Sarah, Beebe, Hanna, Wyld, David K. and Neale, Rachel E. (2020). Supporting patients and carers affected by pancreatic cancer: a feasibility study of a counselling intervention. European Journal of Oncology Nursing, 46 101729, 101729. doi: 10.1016/j.ejon.2020.101729 |
|
2020 Conference Publication P3BEP (ANZUP 1302): an international randomized phase III trial of accelerated versus standard BEP chemotherapy for adult and pediatric male and female patients with intermediate and poor-risk metastatic germ cell tumors (GCTs)Subramaniam, Shalini, Toner, Guy C., Stockler, Martin R., Martin, Andrew James, Pashankar, Farzana D., Frazier, A. Lindsay, Mazhar, Danish, Ford, Kate, Walpole, Euan Thomas, Stevanovic, Amanda Gwendolyn, Wyld, David, Troon, Simon, Hanning, Fritha J., Birtle, Alison Jane, Wheater, Matthew James, Huddart, Robert A., White, Jeff D., Spunt, Sheri L. and Grimison, Peter S. (2020). P3BEP (ANZUP 1302): an international randomized phase III trial of accelerated versus standard BEP chemotherapy for adult and pediatric male and female patients with intermediate and poor-risk metastatic germ cell tumors (GCTs). Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San Francisco, CA USA, 13-15 February 2020. Alexandria, VA: American Society of Clinical Oncology. |
|
2020 Journal Article The economic impact on Australian patients with neuroendocrine tumoursGordon, Louisa G., Elliott, Thomas M., Wakelin, Kate, Leyden, Simone, Leyden, John, Michael, Michael, Pavlakis, Nick, Mumford, Jan, Segelov, Eva and Wyld, David K. (2020). The economic impact on Australian patients with neuroendocrine tumours. The Patient - Patient-Centered Outcomes Research, 13 (3), 363-373. doi: 10.1007/s40271-020-00412-z |
|
2020 Journal Article The INTERNET STUDY: a phase II study of everolimus in patients with fluorodeoxyglucose (18F) positron-emission tomography positive intermediate grade pancreatic neuroendocrine tumorsLung, Mei Sim, Hicks, Rodney J, Pavlakis, Nick, Link, Emma, Jefford, Michael, Thomson, Benjamin, Wyld, David K, Liauw, Winston, Akhurst, Timothy, Kuru, Narmatha and Michael, Michael (2020). The INTERNET STUDY: a phase II study of everolimus in patients with fluorodeoxyglucose (18F) positron-emission tomography positive intermediate grade pancreatic neuroendocrine tumors. Asia-Pacific Journal of Clinical Oncology, 16 (3) ajco.13307, 150-157. doi: 10.1111/ajco.13307 |
